{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:05:53Z","timestamp":1790625953388,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["12\/IA\/1343"],"award-info":[{"award-number":["12\/IA\/1343"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Azoles are one of the main antifungal classes for the treatment of candidiasis. In the current context of emerging drug resistance, most studies have focused on Candida albicans, Candida glabrata or Candida auris but, so far, less is known about the underlying mechanisms of resistance in other species, including Candida orthopsilosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We investigated azole resistance in a C. orthopsilosis clinical isolate recovered from a patient with haematological malignancy receiving fluconazole prophylaxis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Antifungal susceptibility to fluconazole was determined in vitro (CLSI M27-A3) and in vivo (in a Galleria mellonella model of invasive candidiasis). The CoERG11 gene was then sequenced and amino acid substitutions identified were mapped on the predicted 3D structure of CoErg11p. A clustered regularly interspaced short palindromic repeat-Cas9 (CRISPR-Cas9) genome-editing strategy was used to introduce relevant mutations into a fluconazole-susceptible C. orthopsilosis isolate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with unrelated C. orthopsilosis isolates, the clinical isolate exhibited both in vitro and in vivo fluconazole resistance. Sequencing of the CoERG11 gene identified several amino acid substitutions, including two possibly involved in fluconazole resistance (L376I and G458S). Both mutations mapped close to the active site of CoErg11p. Engineering these mutations in a different genetic background using CRISPR-Cas9 demonstrated that G458S, but not L376I, confers resistance to fluconazole and voriconazole.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data show that the G458S amino acid substitution in CoERG11p, but not L376I, contributes to azole resistance in C. orthopsilosis. In addition to highlighting the potential of CRISPR-Cas9 technology for precise genome editing in the field of antifungal resistance, we discuss some points that are critical to improving its efficiency.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jac\/dkz204","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T19:13:07Z","timestamp":1555441987000},"page":"2230-2238","source":"Crossref","is-referenced-by-count":27,"title":["Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis"],"prefix":"10.1093","volume":"74","author":[{"given":"Florent","family":"Morio","sequence":"first","affiliation":[{"name":"Laboratoire de Parasitologie-Mycologie, CHU de Nantes, Nantes, France"},{"name":"D\u00e9partement de Parasitologie et Mycologie M\u00e9dicale, Universit\u00e9 de Nantes, Nantes Atlantique Universit\u00e9s, EA1155 \u2013 IICiMed, Facult\u00e9 de Pharmacie, Nantes, France"},{"name":"School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lombardi","sequence":"additional","affiliation":[{"name":"School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Tirol, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Loge","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Chimie Th\u00e9rapeutique, Universit\u00e9 de Nantes, Nantes Atlantique Universit\u00e9s, EA1155 \u2013 IICiMed, Facult\u00e9 de Pharmacie, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Robert","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Parasitologie et Mycologie M\u00e9dicale, Universit\u00e9 de Nantes, Nantes Atlantique Universit\u00e9s, EA1155 \u2013 IICiMed, Facult\u00e9 de Pharmacie, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Graessle","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Tirol, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Bodin","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Parasitologie et Mycologie M\u00e9dicale, Universit\u00e9 de Nantes, Nantes Atlantique Universit\u00e9s, EA1155 \u2013 IICiMed, Facult\u00e9 de Pharmacie, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Tirol, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Butler","sequence":"additional","affiliation":[{"name":"School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Le Pape","sequence":"additional","affiliation":[{"name":"Laboratoire de Parasitologie-Mycologie, CHU de Nantes, Nantes, France"},{"name":"D\u00e9partement de Parasitologie et Mycologie M\u00e9dicale, Universit\u00e9 de Nantes, Nantes Atlantique Universit\u00e9s, EA1155 \u2013 IICiMed, Facult\u00e9 de Pharmacie, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"key":"2019071909303658400_dkz204-B1","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1128\/AAC.00466-11","article-title":"Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia","volume":"55","author":"Cant\u00f3n","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B2","doi-asserted-by":"crossref","first-page":"18026.","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2019071909303658400_dkz204-B3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JCM.43.1.284-292.2005","article-title":"Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III","volume":"43","author":"Tavanti","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019071909303658400_dkz204-B4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diagmicrobio.2016.08.028","article-title":"Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex","volume":"86","author":"Haas","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019071909303658400_dkz204-B5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.funbio.2015.04.007","article-title":"DNA barcoding of fungi causing infections in humans and animals","volume":"120","author":"Irinyi","year":"2016","journal-title":"Fungal Biol"},{"key":"2019071909303658400_dkz204-B6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/gbe\/evu082","article-title":"Genome comparison of Candida orthopsilosis clinical strains reveals the existence of hybrids between two distinct subspecies","volume":"6","author":"Pryszcz","year":"2014","journal-title":"Genome Biol Evol"},{"key":"2019071909303658400_dkz204-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1006404","article-title":"Multiple origins of the pathogenic yeast Candida orthopsilosis by separate hybridizations between two parental species","volume":"12","author":"Schr\u00f6der","year":"2016","journal-title":"PLoS Genet"},{"key":"2019071909303658400_dkz204-B8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijantimicag.2017.05.012","article-title":"Molecular basis of antifungal drug resistance in yeasts","volume":"50","author":"Morio","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2019071909303658400_dkz204-B9","doi-asserted-by":"crossref","first-page":"e1006209.","DOI":"10.1371\/journal.ppat.1006209","article-title":"Location, location, location: use of CRISPR-Cas9 for genome editing in human pathogenic fungi","volume":"13","author":"Mitchell","year":"2017","journal-title":"PLoS Pathog"},{"key":"2019071909303658400_dkz204-B10","year":"2008"},{"key":"2019071909303658400_dkz204-B11","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J Biol Chem"},{"key":"2019071909303658400_dkz204-B12","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2019071909303658400_dkz204-B13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"2019071909303658400_dkz204-B14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1099\/jmm.0.025494-0","article-title":"Caspofungin primes the immune response of the larvae of Galleria mellonella and induces a non-specific antimicrobial response","volume":"60","author":"Kelly","year":"2011","journal-title":"J Med Microbiol"},{"key":"2019071909303658400_dkz204-B15","doi-asserted-by":"crossref","first-page":"8051.","DOI":"10.1038\/s41598-017-08500-1","article-title":"Gene editing in clinical isolates of Candida parapsilosis using CRISPR\/Cas9","volume":"7","author":"Lombardi","year":"2017","journal-title":"Sci Rep"},{"key":"2019071909303658400_dkz204-B16","doi-asserted-by":"crossref","first-page":"e00125-19","DOI":"10.1128\/mSphere.00125-19","article-title":"Plasmid-based CRISPR-Cas9 gene editing in multiple Candida species","volume":"4","author":"Lombardi","year":"2019","journal-title":"mSphere"},{"key":"2019071909303658400_dkz204-B17","doi-asserted-by":"crossref","first-page":"e1004365.","DOI":"10.1371\/journal.ppat.1004365","article-title":"Comparative phenotypic analysis of the major fungal pathogens Candida parapsilosis and Candida albicans","volume":"10","author":"Holland","year":"2014","journal-title":"PLoS Pathog"},{"key":"2019071909303658400_dkz204-B18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/molbev\/mst042","article-title":"Comparative genome analysis and gene finding in Candida species using CGOB","volume":"30","author":"Maguire","year":"2013","journal-title":"Mol Biol Evol"},{"key":"2019071909303658400_dkz204-B19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/AAC.05389-11","article-title":"S279 point mutations in Candida albicans sterol 14-\u03b1 demethylase (CYP51) reduce in vitro inhibition by fluconazole","volume":"56","author":"Warrilow","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B21","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1128\/AAC.00842-15","article-title":"Fluconazole and voriconazole resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene","volume":"59","author":"Branco","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B22","doi-asserted-by":"crossref","first-page":"575.e1","DOI":"10.1016\/j.cmi.2017.02.002","article-title":"Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance","volume":"23","author":"Branco","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2019071909303658400_dkz204-B23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/AAC.04613-14","article-title":"Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.funbio.2015.06.002","article-title":"Galleria mellonella: an invertebrate model to study pathogenicity in correctly defined fungal species","volume":"120","author":"Binder","year":"2016","journal-title":"Fungal Biol"},{"key":"2019071909303658400_dkz204-B25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jac\/dky122","article-title":"CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates","volume":"73","author":"Rizzato","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2019071909303658400_dkz204-B26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1999.1136","article-title":"The G464S amino acid substitution in Candida albicans sterol 14-demethylase causes fluconazole resistance in the clinic through reduced affinity","volume":"19","author":"Kelly","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2019071909303658400_dkz204-B27","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","article-title":"Contribution of mutations in the cytochrome P450 14\u03b1-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans","volume":"145","author":"Marichal","year":"1999","journal-title":"Microbiology"},{"key":"2019071909303658400_dkz204-B28","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.42.2.241","article-title":"Amino acid substitutions in the cytochrome p-450 lanosterol 14-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents","volume":"42","author":"Sanglard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B30","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1128\/AAC.48.6.2124-2131.2004","article-title":"Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles","volume":"48","author":"Chau","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B31","doi-asserted-by":"crossref","first-page":"e21239.","DOI":"10.1371\/journal.pone.0021239","article-title":"Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance","volume":"6","author":"Alvarez-Rueda","year":"2011","journal-title":"PLoS One"},{"key":"2019071909303658400_dkz204-B32","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.01645-09","article-title":"Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection","volume":"54","author":"MacCallum","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B33","doi-asserted-by":"crossref","first-page":"e1500248.","DOI":"10.1126\/sciadv.1500248","article-title":"A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families","volume":"1","author":"Vyas","year":"2015","journal-title":"Sci Adv"},{"key":"2019071909303658400_dkz204-B34","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00894-18","article-title":"Cas9\/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus","volume":"62","author":"Umeyama","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019071909303658400_dkz204-B35","doi-asserted-by":"crossref","first-page":"40638","DOI":"10.1038\/srep40638","article-title":"Profiling single-guide RNA specificity reveals a mismatch sensitive core sequence","volume":"7","author":"Zheng","year":"2017","journal-title":"Sci Rep"},{"key":"2019071909303658400_dkz204-B36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkz204\/28671071\/dkz204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/8\/2230\/28963429\/dkz204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T14:38:28Z","timestamp":1607265508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/8\/2230\/5491491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,5,18]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz204","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,5,18]]}}}